HER2 and Chromosome 17 Effect on Patient Outcome in the N9831 Adjuvant Trastuzumab Trial

PURPOSE: We examined associations between tumor characteristics (human epidermal growth factor receptor 2 [HER2] protein expression, HER2 gene and chromosome 17 copy number, hormone receptor status) and disease-free survival (DFS) of patients in the N9831 adjuvant trastuzumab trial. PATIENTS AND MET...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Perez, Edith A., Reinholz, Monica M., Hillman, David W., Tenner, Kathleen S., Schroeder, Matthew J., Davidson, Nancy E., Martino, Silvana, Sledge, George W., Harris, Lyndsay N., Gralow, Julie R., Dueck, Amylou C., Ketterling, Rhett P., Ingle, James N., Lingle, Wilma L., Kaufman, Peter A., Visscher, Daniel W., Jenkins, Robert B.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: American Society of Clinical Oncology 2010
Onderwerpen:
Original Reports
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2954132/
https://ncbi.nlm.nih.gov/pubmed/20697084
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.26.2154
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items